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http://dx.doi.org/10.1016/j.tcmj.2013.01.004A 57-year-old woman with end-stage renal disease received
a kidney transplant using a kidney from a cadaver. The post-
operative creatinine level gradually recovered from 9.6 mg/dL to
2.8 mg/dL. A kidney biopsy was performed 9 months post-
transplantation because of worsening renal function and pathol-
ogy revealed tacrolimus nephrotoxicity. Her immunosuppressantthe pulmonary venules in the
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ddhist Compassion Relief Tzu Chiwas switched to sirolimus. Ten months after the biopsy, she was
admitted to hospital because of pulmonary hypertension with
a systolic pressure of 90 mmHg and right ventricle overload. She
died of sepsis 4 days later. After autopsy, histopathology of the
lungs conﬁrmed changes in the pulmonary venous system with
the lumina narrowed by extensive intimal ﬁbrosis diagnostic of
pulmonary veno-occlusive disease (PVOD; Fig. 1).
PVOD is currently classiﬁed as a subgroup of pulmonary artery
hypertension (PAH) and accounts for 5e10% of cases initially con-
sidered to be idiopathic PAH. The cause of PVOD is not known.
PVOD is associated with respiratory infections (especially virus
infections), exposure to toxins, (chemotherapy), bone marrow
transplantation, and renal transplantation. Only one case of PVOD
following renal transplantation has been reported. Pathologists
suggest the obstructive changes in the pulmonary veins are
thrombotic in origin, such as in our case. PVOD is characterized by
a poor prognosis and the possibility of developing severe pulmo-
nary edema with speciﬁc PAH therapy. Lung transplantation is the
treatment of choice.
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